Open AccessA Multi-Institutional Phase II Study of the Efficacy and Tolerability of Lapatinib in Patients with Advanced Hepatocellular Carcinomas
Author(s) -
Tanios BekaiiSaab,
Joseph Markowitz,
Nichole Prescott,
Wolfgang Sadée,
Nyla A. Heerema,
Lai Wei,
Zunyan Dai,
Audrey C. Papp,
Angela Campbell,
Kristy Culler,
Catherine Balint,
Bert H. O’Neil,
Ruey Min Lee,
Mark M. Zalupski,
Janet Dancey,
Helen Chen,
Michael R. Grever,
Charis Eng,
Miguel A. VillalonaCalero
Publication year - 2009
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/pdaj-fz64
Subject(s) - tolerability , lapatinib , hepatocellular carcinoma , oncology , medicine , trastuzumab , cancer , adverse effect , breast cancer